TipRanks
Futurefuel Corp. (DE:3FF)
FRANKFURT:3FF
Germany Market
EarningsQ2 2026 Earnings Report

Futurefuel (3FF) Q2 2026 Earnings Report

1 Followers

DE:3FF Q2 2026 EPS Results

Actual EPS€0.22
Consensus EPS―
Beat/Miss―
One Year Ago EPS-€0.21

DE:3FF Q2 2026 Revenue Results

Actual Revenue€68.23M
Expected Revenue―
Beat/Miss―
YoY Revenue Growth+120.69%

Earnings Announcement Details

QuarterQ2 2026
Date08/10/2026
TimeAfter Close
Conference CallMonday, August 10, 2026
DE:3FF Upcoming Earnings
Futurefuel's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:3FF Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 10, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized a clear operational turnaround and return to profitability driven by strong revenue growth (+120.7%), higher volumes (+40.4%), improved price realization (+80.2%) and positive adjusted EBITDA, alongside strengthened liquidity and favorable regulatory tailwinds (RFS mandates and 45Z clarity). Key achievements include large YoY gross profit recovery, production increases, improved capacity utilization, customer-funded expansion commitments and a $22M credit monetization expected in H2. Offsetting these positives are persistent elevated feedstock costs, a multi-week biodiesel outage during the quarter, hedging-related volatility, moderate remaining utilization headroom, and long lead times for new customer builds. On balance, the positive developments and financial momentum materially outweigh the challenges.
Company Guidance
Guidance emphasized a return to profitable growth with the company "on pace to deliver positive adjusted EBITDA for the full year 2026," and management expects Q3 production to exceed Q2 levels; Q2 metrics included revenue of $78.7 million (up 120.7% YoY), total production +26% YoY, total volume growth +40.4% and blended price +80.2%, total gross profit $15.0 million (vs. a $12.4 million loss prior-year), net income $11.4 million (vs. a $14.2 million loss), and adjusted EBITDA $11.8 million (vs. an $11.4 million loss); chemicals: revenue $25.8 million (+34% production YoY), gross profit $5.0 million, capacity utilization 65% (up from 54%) and ~250 million lb annual capacity; biofuels: revenue $52.9 million, production +21% YoY, gross profit $10.1 million, capacity utilization 56% and ~60 million gallons annual biodiesel capacity; cash flow/BS: operating cash flow $18.8 million in Q2, cash $34.3 million at June 30 (up from $22.4 million), $35 million revolver undrawn; capex $8.0 million in Q2 ($2.9M maintenance, $5.1M discretionary), YTD capex $13.4M (customer-funded ~$1.9M Q2, $3.5M YTD); hedging/derivatives impacted results (Q2 benefited ~$9.1M from selling inventory above hedge levels and $3.2M unrealized derivative gains, following a $9M hedging loss in Q1); and management highlighted a secured 4‑year monetization agreement for Section 45Z and small producer credits expected to generate ~$22 million gross in H2 (≈$3M in Q3 and $19M in Q4) and said they will track plant capacity utilization, plant uptime, safety performance and unit product cost to measure progress.
Strong Revenue Growth
Total revenue of $78.7 million in the quarter, an increase of 120.7% versus $35.7 million in the prior-year quarter, driven by higher throughputs, improved mix, and higher average pricing.
Return to Profitability
Net income of $11.4 million compared with a net loss of $14.2 million year-over-year; adjusted EBITDA of $11.8 million versus an adjusted EBITDA loss of $11.4 million in the prior-year period.
Large Improvement in Gross Profit
Total gross profit of $15.0 million versus a gross loss of $12.4 million year-over-year; chemicals gross profit improved to $5.0 million from $1.1 million and biofuels gross profit improved to $10.1 million from a gross loss of $13.5 million.
Material Production and Volume Increases
Total production increased 26% year-over-year in the quarter; total volume growth of 40.4%; chemical segment production up 34% and biofuel production up 21% year-over-year.
Price Realization and Mix Benefits
Average blended price increased by 80.2% year-over-year, contributing materially to revenue and gross profit improvements.
Improved Capacity Utilization
Chemical segment capacity utilization improved to 65% (from 54% prior-year) and biofuel capacity utilization improved to 56%, indicating stronger operating leverage as throughput scales.
Stronger Cash Flow and Liquidity Position
Net cash provided by operations of $18.8 million versus $5.2 million prior-year; cash and cash equivalents of $34.3 million at quarter-end (up from $22.4 million), and a $35 million revolving credit facility with no borrowings.
Regulatory and Credit Monetization Tailwinds
Secured a 4-year agreement to monetize Section 45Z and small producer tax credits; expected gross proceeds of approximately $22 million in the second half of the year ($3 million in Q3 and $19 million in Q4). Additionally, EPA RFS mandates and updated 45Z rules provide favorable regulatory clarity for biodiesel economics.
Customer-Funded Expansion and Pipeline
Customer commit/arrangement referenced for more than $40 million of investment over the next ~3 years to support incremental capacity; customer-funded investments of ~$1.9 million in the quarter (~$3.5 million year-to-date) demonstrate commercial traction and de-risked capacity expansion.

DE:3FF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 05, 2026
2026 (Q3)
- / -
-0.185―
2026 (Q2)
- / 0.22
-0.206206.72% (+0.43)
2026 (Q1)
- / -0.41
-0.349-16.13% (-0.06)
2025 (Q4)
- / -0.24
0.055-526.56% (-0.29)
2025 (Q3)
- / -0.18
-0.023-688.89% (-0.16)
2025 (Q2)
- / -0.21
0.19-208.68% (-0.40)
2025 (Q1)
- / -0.35
0.086-507.07% (-0.44)
2024 (Q4)
- / 0.06
0.463-88.01% (-0.41)
2024 (Q3)
- / -0.02
0.055-142.86% (-0.08)
2024 (Q2)
- / 0.19
-0.195197.33% (+0.38)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed